Form 4: Iradimed Director Hilda Scharen-Guivel Receives Restricted Stock Units

Director Hilda Scharen-Guivel of Iradimed Corporation received 1,811 restricted stock units on December 11, 2024, under the company's 2023 Equity Incentive Plan.

Summary

• Hilda Scharen-Guivel, a director at Iradimed Corporation, was granted 1,811 restricted stock units on December 11, 2024.
• These restricted stock units were awarded under the company's 2023 Equity Incentive Plan.
• The restricted stock units will vest in two equal annual installments, starting on December 11, 2025.
• Upon vesting, each restricted stock unit will convert into one share of common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting equity to directors, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Risks

• The value of the restricted stock units is dependent on the future performance of Iradimed's stock price.
• There is a risk that the stock price could decline before the units vest.

Future Outlook

The director will receive shares of common stock as the restricted stock units vest over the next two years.

Industry Context

The granting of restricted stock units is a common practice for incentivizing directors and aligning their interests with shareholders in the corporate world.

Comparison to Industry Standards

• Many companies in the medical device industry use equity-based compensation to attract and retain key personnel.
• The vesting schedule of two years is fairly standard for restricted stock unit grants.
• The one-for-one conversion ratio of restricted stock units to common stock is also a common practice.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning director interests with company performance.
• Employees may see this as a standard practice for incentivizing leadership.

Next Steps

• The director will receive the first half of the shares on December 11, 2025.
• The director will receive the second half of the shares on December 11, 2026.

Key Dates

Keywords

restricted stock units, equity incentive plan, director, Iradimed, stock options, vesting